Tacrolimus 0.1% is a topical immunomodulator used to manage moderate to severe inflammatory skin conditions, primarily atopic dermatitis and eczema, particularly in patients who do not respond well to conventional corticosteroid therapy. It works by inhibiting calcineurin, which reduces T-cell activation and the release of inflammatory cytokines, leading to reduced redness, itching, and skin irritation. Tacrolimus is steroid-free, making it suitable for long-term use on sensitive skin areas like the face and neck.
